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Background: In the last recent years a new percutaneous procedure, the MitraClip, has been validated for the
treatment of mitral regurgitation. MitraClip procedure is a promising alternative for patients unsuitable for surgery
as it reduces the risk of death related to surgery ensuring a similar result. Few data are present in literature about
the variation of hemodynamic parameters and ventricular coupling after Mitraclip implantation.
Methods: Hemodynamic data of 18 patients enrolled for MitraClip procedure were retrospectively reviewed and
analyzed. Echocardiographic measurements were obtained the day before the procedure (T0) and 21 ± 3 days after
the procedure (T1), including evaluation of Ejection Fraction, mitral valve regurgitation severity and mechanism,
forward Stroke Volume, left atrial volume, estimated systolic pulmonary pressure, non invasive echocardiographic
estimation of single beat ventricular elastance (Es(sb)), arterial elastance (Ea) measured as systolic pressure • 0.9/
Stroke Volume, ventricular arterial coupling (Ea/Es(sb) ratio). Data were expressed as median and interquartile range.
Measures obtained before and after the procedure were compared using Wilcoxon non parametric test for paired
samples.
Results: Mitraclip procedure was effective in reducing regurgitation. We observed an amelioration of
echocardiographic parameters with a reduction of estimated systolic pulmonary pressure (45 to 37,5 p = 0,0002)
and left atrial volume (110 to 93 p = 0,0001). Despite a few cases decreasing in ejection fraction (37 to 35
p = 0,035), the maintained ventricular arterial coupling after the procedure (P = 0,67) was associated with an
increasing in forward stroke volume (60,3 to 78 p = 0,05).
Conclusion: MitraClip is effective in reducing mitral valve regurgitation and determines an amelioration of
hemodynamic parameters with preservation of ventricular arterial coupling.
Keywords: Mitraclip, Ventricular arterial coupling, CardiomechanicIntroduction
Mitral regurgitation (MR) is the second most frequent
valve disease after aortic stenosis [1]. Mitral valve sur-
gery is the standard of care for patients presenting
symptomatic or asymptomatic MR with evidence of left
ventricle (LV) dysfunction or dilation; mitral valve repair
should be the preferred technique when it is expected to
be durable [2]. However, many patients presenting a
high surgical risk are treated with a strict titration of
pharmacological therapy or resynchronization [3].* Correspondence: fabiodoc64@hotmail.com
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distribution, and reproduction in any mediumIn recent years, a new percutaneous procedure using
the MitraClipW has been validated for the treatment of
mitral regurgitation. The positioning of a clip approxi-
mates leaflets at different locations mimicking Alfieri’s
surgical suture and creating a double orifice mitral valve.
For large orifices more clips can be used to effectively
reduce regurgitant volume [4]. The Everest studies I and
II demonstrated the safety and efficacy of the procedure
[5]. Furthermore, Ussia et al. demonstrated an improve-
ment in quality of life in high surgical risk patients
undergoing the MitraClip procedure [6]. Therefore, the
MitraClip procedure is considered to be a promising al-
ternative for patients unsuitable for surgery ensuring a
similar result.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tients with advanced heart failure is that the acute correc-
tion of MR could further impair LV systolic performance,
leading to a low or even lower cardiac output state [7,8].
Sunagawa demonstrated that the stroke volume pro-
duced by the heart is determined by the interaction
between ventricular end-systolic elastance and arterial
elastance [9]. Ventricular end-systolic elastance (Ees) is
defined by the slope of the end-systolic pressure-volume
relationship (ESPVR) and is a measure of the contractil-
ity of the left ventricle, which is not influenced by pre-
load changes. Arterial elastance (Ea) is considered a
good index of vascular load and is determined using the
compliance, impedance and resistances of the arterial
system. End-systolic pressure follows maximal ejection
pressure because end-systole occurs as LV relaxation
starts. Therefore, it can be approximated using the ratio
of 90% of the systolic arterial pressure to Stroke volume
(SV) [10]. Sagawa et al. demonstrated that the cardiovas-
cular system is efficient and produces the maximal
stroke work when the Ea/Ees ratio is 0.5-1 [11,12].
Because measuring Ees varying preload and ventricular
end-systolic pressures invasively is difficult in clinical
practice, single-beat methods were developed and vali-
dated for obtaining the Ees value (Ees(SB)) [13]. In par-
ticular, the Ees [SB] can be evaluated by measuring the LV
ejection fraction (EF), Stroke volume (SV), pre-ejection
time and systolic time interval when coupled with the sys-
tolic and diastolic arterial pressures [14] (Figure 1).
For this reason, we aimed to evaluate the hemodynamic
effects of the MitraClip procedure, with particularFigure 1 Left ventricular end-systolic elastance was calculated by the
display the evaluation of ejection fraction (left panel) and pre-ejection and
ventricular elastance at arterial end-diastole (End) was measured according
• tNd i = 0, ENd(est) = 0.0275 - 0.165 • EF + 0.3656 • (Pd/Pes) + 0.515 • ENd(avg) where
for i = 1 to 7, respectively. The value for tNd was determined by the ratio o
(R wave to end-flow), with the time of onset and termination of flow defin
invasively obtained.emphasis on cardiomechanics, by non invasive evaluation
of ventriculo-arterial coupling.Methods
After receiving approval from the ethical committee for
human biomedical investigation of Azienda Ospedaliero
Universitaria Pisana, a retrospective analysis of pro-
spectively collected data from patients who had under-
gone the MitraClip procedure was established. Patients
with high surgical risk who met the echocardiographic
criteria as defined by EVEREST II were included
[15,16]. The parameters were measured by a single ex-
pert operator using a CX 50 ultrasound system (Philips,
Bothell, WA 98041 USA) ) and a S5-1 Sector Array
Transducer (Philips, Bothell, WA 98041 USA) the day
before the procedure (T0) and after a period of 21 ± 3
days after the procedure (T1) in all patients.
The analysis included the following: demographic data;
an evaluation of the logistic EuroSCORE; mechanism of
mitral regurgitation; evaluation of mitral regurgitation
severity using a multiparametric quantitative and quali-
tative analysis as described in Table 1 and semiquantitive
analysis using vena contracta; the mean transmitral gra-
dient; left ventricular end-diastolic and end-systolic vol-
umes; the echocardiographic estimation of systolic
pulmonary arterial pressure; ejection fraction; the non-
invasive estimation of Ees(SB) elastance (Figure 1) [14];
arterial elastance (Ea) assessed as the ratio between 0,9*
systolic pressure to Stroke Volume; and the Ea/Ees(SB)
ratio. All data were analysed offline.single-beat method validated by Chen et al. [14]. The echo figures
ejection time (right panel) using aortic Doppler waveform. Normalized
to the formula: Ees(sb) = [Pd - (ENd(est) • Ps • 0.9)]/[SV • ENd(est)], ENd(avg) = ∑ ai
ai are (0.35695, -7.2266, 74.249, -307.39, 684.54. -856.92, 571.95, -159.1)
f pre-ejection period (R wave to flow onset) to total systolic period
ed Doppler. Systolic (Ps) and diastolic (Pd) blood pressure were
Table 1 Echocardiographic criteria used to define severity of mitral regurgitation based on multi parametric
quantitative and qualitative analysis as suggested by american Society of Echocardiography Reccomendations [16]
Mitral Regurgitation Criteria
Grade Mild 1+ Moderate 2+ Moderate to severe 3+ Severe 4+
Color flow Doppler <4 cm2 or <10 cm2
LA area
4-6 cm2 or 10-30% of left
LA area
6 to <8 cm2 or 30% to <40% of
LA area
>8 cm2 or >40% of
LA area
Regurgitant Volume (ml/beat) <30 30-44 45-59 >60
Regurgitant Fraction (%) <30 30-39 40-49 >50
Pulmonary Vein flow Systolic Dominant Diastolic Dominant All Diastolic Systolic Reversal
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The data are presented as the mean ± SD or the median
± interquartile range. A non-parametric Wilcoxon test
for paired samples was used because of the small num-
ber of patients. Results were considered significant when
p < 0,05. Correlations between the Ees(SB) and the
ejection fraction were evaluated using the Spearman
coefficient.
Results
We reviewed forty cases of the MitraClip procedure
performed over two years (from June 2010 to JuneTable 2 Echocardiographic parameters assessed in awake pat
at discharge from hospital
Before MitraClip pro
MV regurgitation Jet area (cm2) 11,8
8,3 to 14,5
Vena contracta (cm) 0,8
0,65 to 0,
Left atrial volume (ml) 110,5
88 to 122
Estimated Systolic Pulmonary Pressure (mmhg) 45
35 to 50
Ejection Fraction (%) 37
30,25 to 43,
Mean Transmitralic Gradient (mmHg) 2,95
2 to 4
End Systolic Volume (ml) 106
55,5 to 129
End Diastolic Volume (ml) 159,5
113 to 19
Forward stroke volume (ml) 60,3
49,85 to 73
Arterial elastance (mmhg/ml) 1,225
0,937 to 1,
End Ejection Systolic Elastance (SB) (mmHg/ml) 1,43
1,286 to 1,
Ventriculo-Arterial Coupling (Ea/Es) 0,765
0,654 to 0,8
Data are expressed as median ± IR. P significative < 0,05.2012). We found complete echocardiographic data for
18 patients (11 males and 7 females) with a mean age of
73 ± 1 years, who were then considered in the analysis.
The patients presented a logistic EuroSCORE of 30,8
±25,2. All patients presented a diagnosis of functional
MV regurgitation. The results are summarized in Table 2.
The MitraClip procedure effectively reduced MV regur-
gitation (Figure 2) without causing a significant increase
in the mean transmitral diastolic gradient. We observed
a reduction in the left atrial volume, estimated systolic
pulmonary pressure and end-systolic and end-diastolic
LV volumes. Despite a decrease in the ejection fraction,ients measured the day before MitraClip positioning and
cedure (T0) After MitraClip procedure (T1) p
6,3 P < 0,0001
75 4,7 to 8
0,4 P < 0,0001
9 0,3 to 0,42
93,5 P < 0,0001
66 to 105
37,5 P = 0,0002
30 to 45
35 P = 0,035
125 31,9 to 47,25
3 P = 0,15
3 to 4
97 P = 0,001
,75 40,75 to 120,5
151 P < 0,0001
7 89 to 180
78 P = 0,05
,1 54,5 to 86
1,22 P = 0,30
44 0,794 to 1,44
1,46 P = 0,37
82 1,02 to 1,75
0,765 P = 0,67
39 0,689 to 0,839
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ume. We did not observe variations in the end-systolic
single-beat elastance or arterial elastance or the Ea/Ees(Sb)
ratio. There was no correlation between the Ees(SB) and
the ejection fraction before (Spearman coefficient =0,2) or
after the procedure (Spearman coefficient = 0,3) (Figure 3).
Following the MitraClip procedure, the NYHA class
was significantly reduced in our patients (p = 0,0001)
(Figure 4).
Discussion
The main finding of this study was that the reduction of
mitral regurgitation with MitraClip procedure is associ-
ated with preserved ventricular end systolic elastance
(single beat) not correlated with the reduction of EF, and
unchanged ventriculo-arterial coupling defined as Ea/Ees
(SB) at an early follow-up.
A percutaneous edge-to-edge procedure may be con-
sidered in patients with symptomatic severe MR who
fulfill the echo criteria of eligibility, are judged inoper-
able or at high surgical risk by a ‘heart team’, and have a
life expectancy greater than 1 year (recommendation
class IIb, level of evidence C) [2]. The impact of percu-
taneous therapy allows the treatment of patients for
whom the only alternative is amelioration using pharma-
cological therapy without a significant improvement in
the duration or quality of life due to unacceptable surgi-
cal risk.
Our study confirms the hemodynamic effects of the
MitraClip procedure for patients with severe mitral re-
gurgitation. All patients presented a significant reductionFigure 2 Reduction of Mitral Valve regurgitation assessed with echoc
positioning (T0) and after 21 ± 3 days from procedure.of mitral regurgitation at the time of control (T1). The
reduction of MV insufficiency was associated with low-
ering of PAPs, left ventricular and atrial volumes and
amelioration of the NYHA class status.
We hypothesize that the observed reduction of the
ejection fraction could not be an index of decreased sys-
tolic function, rather a consequence of a reduced pre-
load, as evidenced by the reduction of the left atrial and
ventricular volumes. Left ventricular unloading is con-
sidered one of the most important determinants of the
reduction of clinical symptoms in patients after correc-
tion of mitral regurgitation by any technique (19). In the
MitraClip procedure closing the MV regurgitant orifice
lowers the regurgitation volume and the left ventricular
and diastolic volumes during the next diastole.
The analysis of ventriculo-arterial coupling in this sub-
set of patients produced interesting results.
Siegel et al. have shown that successful MV repair with
the MitraClip system results in an immediate improve-
ment in FSV, CO, and LV loading conditions and an
acute reduction of the systemic vascular resistance [17].
A post-hoc analysis has demonstrated that the hemo-
dynamic benefit of the percutaneous procedure is higher
in a particular subset of patients with a low CI and a
high left-sided filling pressure and PAP [18].
Ken-ichi Imasaka et al. demonstrated that the early
surgical repair of organic mitral valve regurgitation
influenced ventricular coupling in patients with pre-
served and impaired LV function. Measuring ventricular
and arterial coupling before and 1 month after surgery,
they showed that Ea increased after the procedure in allardiographic method in awake patients before MitraClip
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Figure 3 Lack of correlation between Single Beat End Systolic Elastance (EesSb) and Ejection fraction before (T0) (left) and after 21 ± 3
days (T1) from MitraClip positioning (right).
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creased their contractility to rebalance ventricular coup-
ling [19].
Most of our patients presented impaired function with
a maintained optimal Ea/Ees(SB) ratio before the pro-
cedure. We demonstrated that contractility was pre-
served in all patients and that Ea was not increased after
the procedure. As a consequence, the lack of variation in
the Ea/Ees(SB) ratio is the expression of maintained
ventriculo-arterial coupling and ventricular performance
after the percutaneous closure of the defect. Considering
stroke volume as a function of ventriculo-arterial coup-
ling, we can deduce that, despite reducing the EF, the
combination of the restoration of normal blood ejection
and the preserved Ea/Ees ratio increases the forward “ef-
fective” stroke volume after the MitraClip procedure.
Our findings are supported by the recently published
data by Gaemperli et al. who investigated the acute
behavior of pressure volume relationships in patientsFigure 4 NYHA class status assessed before MitraClip positioning (T0undergoing Mitraclip procedure. Based on the invasive
measurements obtained with conductance catheters dur-
ing the intervention they found no acute variations of
PV loop area and increased CI following MV repair [20].
Our study shows limitations due to its retrospective
design and the small number of patients analyzed. Our
results have been obtained in a non-invasive manner
and we cannot exclude differences if data were obtained
invasively monitoring ventricular and vascular load de-
terminants, although recent evidence seems to support
our results [20]. However, this study is the first to non
invasively describe midterm preserved ventricular per-
formance and the low impact of MitraClip repair of MV
regurgitation on LV afterload (Ea) in patients with im-
paired ventricular function. Larger prospective studies
are needed to confirm these results focusing on relation
between preservation of cardiomechanic parameters and
clinical status during follow up in patients undergoing
MitraClip procedure.) and after 21 ± 3 days (T1) from procedure.
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Written informed consent was obtained from the pa-
tients for publication of this report and any accompany-
ing images.
Key message:
 MitraClip is an effective procedure in reducing
mitral valve regurgitation in high surgical risk
patients.
 MitraClip procedure has favorable hemodynamic
impact. The reduction of Mitral regurgitation is
associated with preserved Ea/Ees(sb) ratio and
increased forward stroke volume.
 Non invasive evaluation of cardiomechanics is
feasible and may be useful in patients undergoing
MitraClip procedure.
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